Diastereoselective synthesis of cyclic β2,3-amino acids utilizing 4-substituted-1,3-oxazinan-6-ones
-
Add time:08/09/2019 Source:sciencedirect.com
The 4-substituted-1,3-oxazinan-6-one scaffold is a versatile synthon enabling access to a diverse array of β-amino acid derivatives. In this study, the synthetic utility of the 1,3-oxazinan-6-one is expanded to include the diastereoselective synthesis of cyclic β2,3-amino acids. Enolate chemistry is used to first alkylate the 4-vinyl, 4-allyl, and 4-butenyl oxazinan-6-ones with various alkenyl electrophiles, in high dr. The resulting 4,5-bis-alkene adducts are then transformed into 4,5-cyclic-1,3-oxazinan-6-ones utilizing the ring closing metathesis reaction. The metathesis products are subsequently converted into a variety of five-, six-, and seven-membered cyclic β2,3-amino acids. The research further highlights the 1,3-oxazinan-6-one as a versatile synthon for producing β-amino acid derivatives.
We also recommend Trading Suppliers and Manufacturers of 4,5-BIS(BENZYLOXY)-2-METHYLBENZOIC ACID (cas 127531-39-9). Pls Click Website Link as below: cas 127531-39-9 suppliers
Prev:Synthesis of {15-benzyloxy-3,7,11,17-tetraazabicyclo[11.3.1]heptadeca-1(17),13,15-triene}nickel(II) perchlorate and its analogs, and their catalytic behavior in reductive debromination of 1-bromo-4-tert-butylbenzene
Next:Lewis acid-catalysed nucleophilic opening of a bicyclic hemiaminal followed by ring contraction: Access to functionalized L-idonojirimycin derivatives) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Lewis acid-catalysed nucleophilic opening of a bicyclic hemiaminal followed by ring contraction: Access to functionalized L-idonojirimycin derivatives08/10/2019
- Synthesis of {15-benzyloxy-3,7,11,17-tetraazabicyclo[11.3.1]heptadeca-1(17),13,15-triene}nickel(II) perchlorate and its analogs, and their catalytic behavior in reductive debromination of 1-bromo-4-tert-butylbenzene08/08/2019
- Enantioselective synthesis of α-benzyloxy-ω-alkenals: application to the synthesis of (+)-exo-brevicomin, (+)-iso-exo-brevicomin, and (−)-isolaurepan08/07/2019
-
Health and Chemical more >


